Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InviCare is a French biotechnology company focused on developing innovative solutions to prevent and treat infections associated with medical implants, particularly in the dental field. The company's core technology is InviGel, a patented, biocompatible hydrogel designed to protect dental implants from bacterial colonization and peri-implantitis. InviGel acts as a protective barrier and can be used during both the placement of the implant and the treatment of existing inflammatory conditions. Based in Lille within the Eurasanté bio-cluster, InviCare leverages advanced materials science to address significant unmet needs in oral health and implantology. The company aims to expand its hydrogel platform to other medical implant applications beyond dentistry. InviCare has received support from regional investment funds and has been recognized for its innovation in the French medtech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invicare.